Home / Cyproterone and Estrogen / Belgium
BE ATC G03HB01 · updated 2 Nov 2026
Cyproterone and Estrogen shortage in Belgium
Is there a Cyproterone and Estrogen shortage in Belgium?
Yes. As of 2 Nov 2026, 2 Cyproterone and Estrogen products are reported short in Belgium, the first since 29 Apr 2026. The company estimate for the return is 12 Nov 2026. Main reason: manufacturing problem.
Not reported short in any other country we track. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Daphne 2 mg - 0.035 mg coat. tabl. 6 x 21 | Ceres Pharma | 29 Apr 2026 | 12 Nov 2026 | Manufacturing problem Delay in production |
| BE | Daphne 2 mg - 0.035 mg coat. tabl. 13 x 21 | Ceres Pharma | 17 Sep 2026 | 12 Nov 2026 | Manufacturing problem Delay in production |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.